Sadia Bashir Hassan
Researcher at Department of Medical Sciences; Cancer Pharmacology and Computational Medicine
- Telephone:
- +46 18 611 52 50
- E-mail:
- Sadia.Hassan@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 61
- Postal address:
- Akademiska sjukhuset, ingång 61
751 85 Uppsala
Publications
Recent publications
-
Part of Oncotarget, p. 6341-6352, 2017
-
Part of Chemometrics and Intelligent Laboratory Systems, p. 24-32, 2015
-
Part of Blood Cancer Journal, 2015
- DOI for Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
- Download full text (pdf) of Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
-
Part of Scientific Reports, 2015
- DOI for In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index
- Download full text (pdf) of In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index
-
Part of Leukemia and Lymphoma, p. 1618-1624, 2014
All publications
Articles in journal
-
Part of Oncotarget, p. 6341-6352, 2017
-
Part of Chemometrics and Intelligent Laboratory Systems, p. 24-32, 2015
-
Part of Blood Cancer Journal, 2015
- DOI for Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
- Download full text (pdf) of Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
-
Part of Scientific Reports, 2015
- DOI for In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index
- Download full text (pdf) of In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index
-
Part of Leukemia and Lymphoma, p. 1618-1624, 2014
-
Repositioning of Quinacrine for Treatment of Acute Myeloid Leukemia
Part of Blood, 2014
-
Part of BMC Cancer, p. 374, 2013
- DOI for Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance
- Download full text (pdf) of Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance
-
The Nanoparticulate Quillaja Saponin BBE Is Selectively Active Towards Renal Cell Carcinoma
Part of Anticancer Research, p. 143-151, 2013
-
Part of ANTI-CANCER AGENT ME, p. 783-790, 2012
-
Novel activity of acriflavine against colorectal cancer tumor cells
Part of Cancer Science, p. 2206-2213, 2011
-
Part of Anticancer Research, p. 11-18, 2009
-
Anti colon cancer components from lebanese sage (Salvia libanotica) essential oil: Mechanistic basis
Part of Cancer Biology & Therapy, p. 1765-1773, 2008
-
Part of Gene Therapy and Molecular Biology, p. 359-370, 2008
-
Cytotoxic effect in vivo and in vitro of CHS 828 on human myeloma cell lines.
Part of Anticancer Drugs, p. 63-70, 2004
-
Part of J Pharmacol Exp Ther, p. 1140, 2001
-
Temporal effects of the novel antitumour pyridyl cyanoguanidine CHS 828, on human lymphoma cells.
Part of Eur J Cancer, p. 260, 2001
-
Part of Cancer Chemother Pharmacol, p. 493, 2000